Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COVID-19 And The Future Of Rx Pricing Policy: An Interview With White House Advisor Grogan

May 15 2020

• By Ramsey Baghdadi

White house in Washington DC (USA)

Related Content

White House Wants To Avoid Fight On Rebates, Get Quick Passage Of Senate Rx Pricing Bill

Nov 08 2019

OMB's Grogan Talks Drug Pricing And Taking On 'Sacred Cows'

Nov 16 2017

Related Companies

Amgen, Inc.

Gilead Sciences, Inc.

Additional Topics

United States Pricing Debate Coronavirus COVID-19 Generic Drugs Government Payers Policy Politics Legislation Reimbursement Infectious Diseases BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.